Treatment of Patients With Teduglutide (GLP-2) for GVHD and Analysis of Paneth Cells of GVHD Patients
Status:
Completed
Trial end date:
2019-12-06
Target enrollment:
Participant gender:
Summary
In this study the investigators evaluate the outcomes of six steroid-refractory GVHD patients
with gastrointestinal signs of GVHD that were treated with teduglutide.